HOXC6 expression, measured through mRNA and protein levels, was found to be prostate-specific and correlated with high serum PSA levels, Gleason score, and TNM stage, implicating this biomarker for PCa detection and metastatic prognosis. The gene discussed is HOXC6; the disease is posterior cortical atrophy.